Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biontech
2
×
boehringer ingelheim
2
×
boston blog main
boston top stories
deals
eli lilly
2
×
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
abbvie
allergan aesthetics
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
biotech
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
covid-19
cullinan oncology
curevac
cystic fibrosis
daniel o'day
detroit blog main
detroit top stories
diabetic macular edema
diagnostics
dogma therapeutics
dyne therapeutics
escape bio
What
bio
2
×
acquisitions
bets
biggest
build
buy
cancer
ceo
comes
companies
company’s
cut
daniel
date
deal
debut
drug
dyne’s
effective
enticed
evidence
gilead
hasn’t
latest
medicines
messenger
microbiome
molecules
moves
mrna
multiple
new
openly
o’day
pharmaceutical
pipeline
primarily
promise
proven
rna
Language
unset
Current search:
biontech
×
bio
×
" eli lilly "
×
" boehringer ingelheim "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines